An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats.
To investigate the pathogenesis of accelerated bone formation in estrogen deficiency, diffusion chambers containing osteoblast-like cells isolated from newborn rat calvariae were transplanted into the peritoneal cavity of sham-operated (sham), ovariectomized (OVX) rats, and OVX rats with supplement of 17 beta-estradiol (OVX + E2). Bone formation in the diffusion chambers transplanted into OVX rats was more accelerated than that transplanted into sham rats and OVX + E2 rats. Osteoblast-like cells cultured with the sera isolated from OVX rats exhibited higher levels of the DNA content in the culture wells, alkaline phosphatase activity, messenger RNA expression for alkaline phosphatase and osteocalcin, calcium content in the cell layer, and formation of bone-like nodules than those exposed to the sera from sham rats and OVX + E2 rats. Antibody against IGF-I almost completely inhibited the increase in DNA contents induced by the sera isolated from OVX rats but partially inhibited alkaline phosphatase activity. Adding IGF-I to the sera isolated from sham rats increased the DNA content to the same extent as that induced by the supplement with the sera from OVX rats but did not increase alkaline phosphatase activity appreciably. Addition of various concentrations of 17 beta-estradiol, interleukin (IL)-1, and IL-6 to the sera isolated from sham rats did not increase the DNA content or alkaline phosphatase activity in the osteoblast-like cells. These results indicate that some systemic factor(s) other than IGF-I, IL-1, and IL-6 may be responsible for the stimulative effect on osteoblast differentiation in the pathogenesis of the accelerated bone formation induced by estrogen deficiency in rats.
Yokose
S
S
Department of Oral Pathology, School of Dentistry, Showa University, Tokyo, Japan.
Ishizuya
T
T
Ikeda
T
T
Nakamura
T
T
Tsurukami
H
H
Kawasaki
K
K
Suda
T
T
Yoshiki
S
S
Yamaguchi
A
A
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001835:Body Weight; D015519:Bone Density; D002454:Cell Differentiation / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D015194:Diffusion Chambers, Culture; D004958:Estradiol / Q000097:blood* / Q000494:pharmacology; D004967:Estrogens / Q000172:deficiency*; D005260:Female; D007334:Insulin-Like Growth Factor I / Q000378:metabolism* / Q000494:pharmacology; D007378:Interleukins / Q000494:pharmacology; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D010012:Osteogenesis; D010052:Ovariectomy; D010529:Peritoneal Cavity; D051381:Rats; D017207:Rats, Sprague-Dawley
D004967:Estrogens; D007378:Interleukins; D004958:Estradiol; D007334:Insulin-Like Growth Factor I; D000469:Alkaline Phosphatase